News
PMCPA News
Press releases appear below, filter by date.
The Prescription Medicines Code of Practice Authority (PMCPA) announced today that it will be working in partnership with The EarthWorks to create a communications programme, including an app to help increase understanding of the Code.
All four companies have brought discredit upon, and reduced confidence in, the pharmaceutical industry. In addition, Pierre Fabre was publicly reprimanded in one case.
The consultation has now closed.
Consultation launched on proposed changes to the ABPI Code of Practice for the Pharmaceutical Industry and the Constitution and Procedure for the Prescription Medicines Code of Practice Authority
The Consultation closed on 10th October 2018. Many thanks to those who contributed.
Pharmaxis Pharmaceuticals Ltd has breached Clause 2 of the ABPI Code of Practice and is the subject of advertisements in the medical, pharmaceutical and nursing press.
Lundbeck Limited, A Menarini Pharma, Bayer plc, HRA Pharma UK and GlaxoSmithKline have each breached Clause 2 of the ABPI Code of Practice and are the subject of advertisements in the medical, pharmaceutical and nursing press.
2014 Interactive Code launched.
Updated guidance and advice documents published.
Transfer of Value Disclosure Crib Notes published
Allergan Limited, Shire Pharmaceuticals Limited, Gedeon Richter and Sanofi have breached the ABPI Code of Practice for the Pharmaceutical Industry.
The amendments result from the new EFPIA Code on Disclosure of Transfers of Value from Pharmaceutical Companies to Healthcare Professionals and Healthcare Organisations and changes to the EFPIA Code on the Promotion of Prescription-Only Medicines to, and Interactions with, Healthcare Professionals. Other amendments to the ABPI Code and the PMCPA Constitution and Procedure were also agreed.
Gedeon Richter (UK) Ltd has breached the ABPI Code of Practice for the Pharmaceutical Industry and brought discredit upon, and reduced confidence in, the pharmaceutical industry.
The PMCPA has issued informal guidance on certification which examines in particular the requirements in relation to projects involving a number of companies and which reflects the changes in the 2016 ABPI Code.
Chiesi Ltd and Vifor Pharma UK Limited have each breached the ABPI Code of Practice for the Pharmaceutical Industry and brought discredit upon, and reduced confidence in, the pharmaceutical industry. In addition, Chiesi was publicly reprimanded.